A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity - 30/11/11
Doi : 10.1016/j.jaci.2011.07.001
Taco W. Kuijpers, MD, PhD a 
, Paul A. Baars, PhD b, Daan J. aan de Kerk, MD a, b, Machiel H. Jansen a, b, Ingrid A.M. Derks b, Robbert G.M. Bredius, MD, PhD d, Elisabeth A.M. Sanders, MD, PhD e, Mirjam van der Burg, MD, PhD f, Marielle Alders, MD, PhD c, Rene A.W. van Lier, MD, PhD b, 
, Paul A. Baars, PhD b, Daan J. aan de Kerk, MD a, b, Machiel H. Jansen a, b, Ingrid A.M. Derks b, Robbert G.M. Bredius, MD, PhD d, Elisabeth A.M. Sanders, MD, PhD e, Mirjam van der Burg, MD, PhD f, Marielle Alders, MD, PhD c, Rene A.W. van Lier, MD, PhD b, a Emma Children’s Hospital, Academic Medical Center, Amsterdam, The Netherlands
b Department of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands
c Department of Clinical Genetics, Academic Medical Center, Amsterdam, The Netherlands
d Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands
e Wilhelmina Children’s Hospital, University Medical Center, Utrecht, The Netherlands
f Department of Immunology, Erasmus Medical Center, Rotterdam, The Netherlands
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 128 - N° 6
P. 1360 - décembre 2011 Retour au numéro
Article précédent
- Predisposition to the development of IL-9–secreting T cells in atopic infants
- Weiguo Yao, Robert S. Tepper, Mark H. Kaplan
- Anaphylaxis to apple and orange seed
- Paul J. Turner, Paul E.A. Gray, Melanie Wong, Nirupama Varese, Jennifer M. Rolland, Robyn O’Hehir, Dianne E. Campbell
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?